Drug Intelligence Bulletin by Keith Graves

Graves and Associates Apr 3, 2022

Drug Testing Positivity On The Rise Among American Workers

Quest Diagnostics released the results of more than 11 million de-identified urine, hair and oral fluid drug test…

Read article →
Graves and Associates Mar 17, 2022

Xylazine is Causing an Increase in Overdoses

A recent study found a steep increase in the number of people who overdose on the veterinary tranquilizer xylazine.…

Read article →
Graves and Associates Mar 5, 2022

Flakka 2.0: Alpha-D2Pv is Now on the Market

A new stimulant drug called “Alpha-D2Pv” is now on the market, and it is already causing concern among law enforcement…

Read article →
Graves and Associates Feb 23, 2022

Cyclazodone, 4 Things Cops Should Know

1: What is Cyclazodone? Cyclazodone is starting to pop up around the United States. It has the potential of becoming…

Read article →
Graves and Associates Feb 18, 2022

Opioid Prescribing Case is Headed to the Supreme Court.

Next month, the Supreme Court will hear a case in which two doctors were convicted of unlawfully dispensing opioids. The…

Read article →
Graves and Associates Feb 17, 2022

Drug Training Podcast 015: Fentanyl and Marijuana

This podcast is sponsored by https://onlinedrugtraining.com. Online Drug Training is putting up new classes as quick…

Read article →
Graves and Associates Feb 15, 2022

Novel Psychoactive Substances: The Next Generation Of Legal Highs

With the ever-growing popularity of designer drugs, it is no surprise that novel psychoactive substances (NPS) are…

Read article →
Graves and Associates Feb 14, 2022

The Drug Czar Could Become A Cabinet-level Position

A new report recommends making the director (“Drug Czar“) of the Office of National Drug Control Policy (ONDCP) a…

Read article →